Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

1 minute read

Published: April 1st, 2025

Discover how Bayesian statistics can enhance clinical trial efficiency and improve decision-making. Our latest white paper, authored by Giles Partington, Consultant Statistician at Phastar, explores how Bayesian methods address key challenges in clinical research. 

Key insights include:

  • How Bayesian frameworks differ from traditional frequentist approaches
  • The role of prior elicitation in enhancing trial design
  • Practical examples of Bayesian methods in action
  • How Bayesian approaches support rare disease and small population trials
  • Insights into adaptive designs, dose optimization, and sample size calculations

Learn how Bayesian techniques can help refine decision-making, optimize trial designs, and improve outcomes. Download the white paper now to gain valuable insights into implementing Bayesian strategies in your clinical trials.

Related articles

Unlock the Power of Real-World Evidence in Clinical Research

Unlock the Power of Real-World Evidence in Clinical Research

February 25th, 2025 1 minute read

Discover how Real-World Evidence (RWE) is revolutionizing drug development and clinical decision-making in our latest...

A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials

A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials

October 10th, 2024 1 minute read

As oncology drug development continues to evolve, the FDA’s Project Optimus is reshaping how clinical trials ap...

Building Effective Partnerships Between Biotechs and CROs to Advance Clinical Development 

Building Effective Partnerships Between Biotechs and CROs to Advance Clinical Development 

September 26th, 2024 1 minute read

The biotech industry is evolving rapidly, with emerging companies leading the charge in clinical development. As outs...